Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending September 9, 2023 (Week 36)
Reporting Area Chlamydia trachomatis infection §
Current weekPrevious 52 weeks Max †Cum YTD 2023 †Cum YTD 2022 †
U.S. Residents, excluding U.S. Territories 9,879 33,418 1,001,217 1,129,989
New England 193 1,650 24,946 36,434
Connecticut - 430 1,155 8,611
Maine 50 74 2,052 2,211
Massachusetts - 709 15,463 19,592
New Hampshire 34 82 1,940 1,982
Rhode Island 91 694 3,407 3,144
Vermont 18 37 929 894
Middle Atlantic 2,258 4,218 134,064 132,977
New Jersey 360 789 23,105 22,945
New York (excluding New York City) 768 1,032 28,669 27,398
New York City 403 1,457 45,325 44,505
Pennsylvania 727 1,233 36,965 38,129
East North Central 1,477 4,622 132,414 158,402
Illinois 72 1,811 34,929 49,467
Indiana 252 837 20,047 23,369
Michigan 222 975 22,438 29,453
Ohio 570 1,204 37,767 38,059
Wisconsin 361 562 17,233 18,054
West North Central 672 2,153 63,235 70,551
Iowa 111 334 9,233 10,270
Kansas 95 325 6,216 9,816
Minnesota 53 497 14,709 15,377
Missouri 413 745 22,057 22,267
Nebraska - 241 5,956 6,732
North Dakota - 92 1,776 2,494
South Dakota - 125 3,288 3,595
South Atlantic 2,627 7,249 223,810 235,538
Delaware 72 210 3,885 3,593
District of Columbia 2 199 5,292 5,648
Florida 1,410 2,786 77,706 73,549
Georgia - 1,597 42,665 50,912
Maryland U NC U U
North Carolina 8 1,445 39,541 45,121
South Carolina 532 766 22,972 25,134
Virginia 582 976 28,832 28,427
West Virginia 21 104 2,917 3,154
East South Central 872 2,450 67,049 77,475
Alabama 569 972 23,685 21,387
Kentucky 258 555 11,347 12,530
Mississippi 45 483 11,767 16,435
Tennessee - 1,094 20,250 27,123
West South Central 471 4,957 127,510 163,314
Arkansas 152 436 11,456 12,494
Louisiana 280 814 24,584 25,493
Oklahoma 39 472 11,287 14,350
Texas - 3,399 80,183 110,977
Mountain 796 2,523 73,627 81,547
Arizona 362 918 26,956 28,613
Colorado - 778 17,041 18,030
Idaho 47 148 3,960 3,996
Montana 18 93 2,114 2,896
Nevada 165 367 8,618 11,217
New Mexico 11 257 6,171 7,824
Utah 163 253 7,631 7,773
Wyoming 30 52 1,136 1,198
Pacific 513 5,049 154,562 173,751
Alaska 50 121 2,766 3,764
California - 4,112 127,653 134,823
Hawaii - 142 - 3,802
Oregon 201 383 10,439 10,950
Washington 262 590 13,704 20,412
U.S. Territories - 124 1,138 3,257
American Samoa - 0 - -
Commonwealth of Northern Mariana Islands - 0 - -
Guam - 0 - -
Puerto Rico - 124 1,138 3,257
U.S. Virgin Islands - 0 - -
Non-U.S. Residents - 7 41 99
Total 9,879 33,518 1,002,396 1,133,345
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • * Case counts for reporting years 2022 and 2023 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/data-statistics/readers-guides/.
  • † Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Beginning in January 2022, only confirmed cases are published to align with the approved CSTE position statement 21-ID-06, whereas in previous years, all case classification statuses were published. This change may cause a decrease in published case counts when compared to previous years.